A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin

使用树脂毒素治疗慢性疼痛的新方法

基本信息

项目摘要

A NOVEL APPROACH FOR CHRONIC PAIN TREATMENT USING RESINIFERATOXIN Resiniferatoxin (RTX), a potent agonist of Transient Receptor Potential Vanilloid 1 (TRPV1), exhibits unique properties that can be utilized to treat chronic pain conditions. TRPV1, a Ca2+ permeable, nonselective cation channel, is activated by physical and chemical stimuli and mediates inflammatory thermal sensation. Presently, this receptor is being considered as a target for analgesics through the evaluation of different antagonists. This proposal will evaluate an approach utilizing agonistic activity of RTX to inhibit nociceptive neurotransmission. In this proposal, using spinal cord slice preparation, we will test the hypothesis that in the short-term, administration of RTX inhibits synaptic transmission by activating presynaptic TRPV1 and causing a depolarization block, thus reducing nociceptive transmission. Then, using behavioral studies, we will test the hypothesis that in the long-term, intrathecal administration of RTX alleviates nociceptive inflammatory pain and the effect is likely to be due to ablation of TRPV1 expressing nerve terminals as a result of the excessive Ca2+ influx. The intrathecal administration of RTX selectively affects TRPV1 expressing nerve terminals of the sensory neurons at the spinal cord without affecting the dorsal root ganglion (DRG) neurons. Since TRPV1 expressing DRG neurons fulfill other efferent functions, the release of inflammatory and neuro/vasoactive substances can be preserved by the intact DRG. Preliminary/published results indicate that RTX causes a slow and sustained activation of TRPV1 leading to nerve terminal depolarization and depression of synaptic transmission. Further, intrathecal administration of RTX promotes a selective and localized ablation of TRPV1 expressing central terminals of sensory neurons at the injection site in the dorsal horn (DH), and leads to sustained pain relief in behavioral models. These studies will enhance our understanding of the role of central TRPV1 in nociceptive transmission. The selective action of RTX on TRPV1 containing nociceptive nerve terminals is a possible strategy to consider for treating chronic, debilitating and terminal pain conditions arising from large and inaccessible areas, due to malignancies of internal organs and bone.
一种使用树脂干扰素治疗慢性疼痛的新方法

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LOUIS S PREMKUMAR其他文献

LOUIS S PREMKUMAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LOUIS S PREMKUMAR', 18)}}的其他基金

A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
  • 批准号:
    7664827
  • 财政年份:
    2009
  • 资助金额:
    $ 26.55万
  • 项目类别:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
  • 批准号:
    8077896
  • 财政年份:
    2009
  • 资助金额:
    $ 26.55万
  • 项目类别:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
  • 批准号:
    8473195
  • 财政年份:
    2009
  • 资助金额:
    $ 26.55万
  • 项目类别:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
  • 批准号:
    7869275
  • 财政年份:
    2009
  • 资助金额:
    $ 26.55万
  • 项目类别:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
糖尿病周围神经病变中的香草酸受体
  • 批准号:
    6930403
  • 财政年份:
    2004
  • 资助金额:
    $ 26.55万
  • 项目类别:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
糖尿病周围神经病变中的香草酸受体
  • 批准号:
    6820139
  • 财政年份:
    2004
  • 资助金额:
    $ 26.55万
  • 项目类别:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
糖尿病周围神经病变中的香草酸受体
  • 批准号:
    7090665
  • 财政年份:
    2004
  • 资助金额:
    $ 26.55万
  • 项目类别:
Role of Vanilloid Receptors in Diabetic Peripheral Neuropathy
香草酸受体在糖尿病周围神经病变中的作用
  • 批准号:
    7682748
  • 财政年份:
    2003
  • 资助金额:
    $ 26.55万
  • 项目类别:
Endogenous Activators of Vanilloid Receptor
香草酸受体内源性激活剂
  • 批准号:
    6361225
  • 财政年份:
    2001
  • 资助金额:
    $ 26.55万
  • 项目类别:
Endogenous Activators of Vanilloid Receptor
香草酸受体内源性激活剂
  • 批准号:
    6639818
  • 财政年份:
    2001
  • 资助金额:
    $ 26.55万
  • 项目类别:

相似海外基金

Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
  • 批准号:
    10778757
  • 财政年份:
    2023
  • 资助金额:
    $ 26.55万
  • 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
  • 批准号:
    10603436
  • 财政年份:
    2023
  • 资助金额:
    $ 26.55万
  • 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
  • 批准号:
    10783106
  • 财政年份:
    2023
  • 资助金额:
    $ 26.55万
  • 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
  • 批准号:
    10740796
  • 财政年份:
    2023
  • 资助金额:
    $ 26.55万
  • 项目类别:
Predicting Pediatric Sickle Cell Disease Acute Pain Using Mathematical Models Based on mHealth Data
使用基于移动健康数据的数学模型预测儿童镰状细胞病急性疼痛
  • 批准号:
    10599401
  • 财政年份:
    2022
  • 资助金额:
    $ 26.55万
  • 项目类别:
Non-Contingent Acute Pain Stress Drives Analgesic Protection in Rats.
非偶然急性疼痛应激驱动大鼠镇痛保护。
  • 批准号:
    575854-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Prefrontal Cortex Hemodynamic Responses to Mindfulness Meditation and Acute Pain
前额皮质血流动力学对正念冥想和急性疼痛的反应
  • 批准号:
    467076
  • 财政年份:
    2021
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Studentship Programs
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
  • 批准号:
    9979265
  • 财政年份:
    2020
  • 资助金额:
    $ 26.55万
  • 项目类别:
Endocannabinoid Metabolism in Acute Pain
急性疼痛中的内源性大麻素代谢
  • 批准号:
    10356880
  • 财政年份:
    2020
  • 资助金额:
    $ 26.55万
  • 项目类别:
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
  • 批准号:
    10218273
  • 财政年份:
    2020
  • 资助金额:
    $ 26.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了